
LIS Technologies, Enterpret, Orbite, Sage, Sollis Health, AMPECO, Nuvig, and Heirloom Secure Key Fundings
Episode 10 delves into notable Series A and B funding updates, beginning with LIS Technologies, Enterpret, and Orbite's Series A accomplishments. The episode then transitions to Series B funding, featuring Sage, Sollis Health, and AMPECO's recent developments. Additionally, the episode highlights substantial Series B rounds for Nuvig Therapeutics and Heirloom, showcasing their strategic growth plans and impact.
Key Points
- LIS Technologies has secured $22 million in Series A funding, surpassing its target by 120%, to advance its CRISLA technology for uranium enrichment.
- Enterpret raised $20.8 million in Series A funding to enhance its AI-enabled customer feedback platform, doubling its annual recurring revenue since May.
- Orbite has completed its Series A funding round with $4 million, partnering with Accor to develop the Spaceflight Gateway Campus for commercial astronaut training.
- Sage raised $35 million in Series B funding to scale its senior living operating system, integrating healthcare, wellness, and community engagement.
- Sollis Health secured $33 million in Series B funding to expand its concierge medicine model, providing 24/7 access to emergency room-level care.
- AMPECO closed a $26 million Series B round to enhance its electric vehicle charging management platform and expand into new markets.
- Nuvig Therapeutics raised $161 million in Series B funding to advance its immunomodulatory therapeutics for autoimmune indications.
- Heirloom secured $150 million in Series B funding to scale its Direct Air Capture technology, aiming to reduce carbon dioxide emissions effectively.
Chapters
0:00 | |
0:14 | |
5:38 | |
11:02 | |
14:15 |
Transcript
Loading transcript...
- / -